Carregant...
Novel Glutamatergic Treatments for Severe Mood Disorders
All currently approved antidepressant medications for major depressive disorder (MDD) and bipolar disorder act primarily on the monoaminergic system and have varying affinities for serotonergic, norepinephrine-ergic, and/or dopaminergic receptors. Unfortunately, these drugs are only effective in app...
Guardat en:
| Publicat a: | Curr Behav Neurosci Rep |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4725605/ https://ncbi.nlm.nih.gov/pubmed/26824031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40473-015-0050-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|